The role of growth factors, cytokines, and vasoactive compounds in obstructive nephropathy

Seminars in Nephrology

Volumn 18, Issue 6, 1998, Pages 622-632

  Klahr, Saulo ^a,b   Morrissey, Jeremiah J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CELL ADHESION MOLECULE; CHEMOATTRACTANT; COLLAGEN TYPE 4; CYTOKINE; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROSIS; INFLAMMATION; INTERSTITIAL NEPHRITIS; KIDNEY INTERSTITIUM; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; URETER OBSTRUCTION;

ANGIOTENSIN II; ANIMALS; EXTRACELLULAR MATRIX PROTEINS; FIBROSIS; HUMANS; KIDNEY TUBULES; NF-KAPPA B; NITRIC OXIDE; PROTEOGLYCANS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; URETERAL OBSTRUCTION; VASOCONSTRICTION;

EID: 0031734613     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Striker GE, Schainuck LI, Cutler RE, Benditt EP: Struc-tural-functional correlations in renal disease. I. A method for assaying and classifying histopathologic changes in renal disease. Hum Pathol 1:615-630, 1970
2. Schainuck LI, Striker GE, Cutler RE, Benditt EP: Struc-tural-functional correlations in renal disease. II: The correlations. Hum Pathol 1:631-641, 1970
3. Bohle A, von Gise H, Mackensen-Haen S, Stark-Jakob B: The obliteration of the postglomerular capillaries and its influence upon the function of both glomeruli and tubuli. Klin Wochenschr59:1043-1051, 1981
4. Bohle A, Mackensen-Haen S, Gise H, et al: The consequences of tubulointerstitial changes for renal function in glomerulopathies, in Amerio A, Cortelli P, Massry SE (eds): Tubulointerstitial Nephropathies, Boston, MA, Kluwer, 1991, pp 29-40
5. Eddy AA: Molecular insights into renal interstitial fi-brosis. J Am Soc Nephrol 7:2495-2508, 1996
6. Nath KA: Tubulointerstitial changes as a major determi-nant in the progression of renal damage. Am J Kidney Dis 20:1-17, 1992
7. Nagle RB, Bulger RE, Cutler RE, et al: Unilateral ob-structive nephropathy in the rabbit. I. Early morphologic, physiologic and histological changes. Lab Invest 28:456-467, 1973
8. Nagle RB, Bulger RE: Unilateral obstructive nephropathy in the rabbit. II. Late morphologic changes. Lab Invest 38:270-278, 1978
9. Sharma AK, Mauer SM, Kirn Y, Michael AF: Intersti-liai fibrosis in obstructive nephropathy. Kidney Int 44:774780, 1993
10. Klahr S: Obstructive nephropathy. Nephrology forum. Kidney Int 54:286-300, 1998
11. Kaneto H, Morrissey J, Klahr S: Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ligation. Kidney Int 44:313-321, 1993
12. Diamond JR, Kees-Folts D, Ding G, et al: Macro-phages, monocyte peptide-1, and TGF-/31 in experimental hydronephrosis. Am J Physiol 266:F926-F933, 1994
13. Roberts AM, Sporn MB: Transforming growth factorβ. Adv Cancer Res 51:107-145, 1988
14. Gibbons GH, Pratt RE, Dzau VJ: Vascular smooth muscle hypertrophy. Autocrine transforming growth factor β1 expression determines growth response to angiotensin II. J Clin Invest 90:451-461, 1992
15. Malyankar UM, Almeida M, Johnson RJ, et al: Osteo-pontin regulation in cultured rat renal epithelial cells. Kidney Int 51:1766-1773, 1997
16. Munger JS, Harpel JG, Gleizes PE, et al: Latent transforming growth factor-/?: Structural features and mechanisms of activation. Kidney Int 51:1376-1382, 1997
17. Böttinger EP, Letterio JJ, Roberts AR: Biology of TGF-β in knockout and transgenic mouse models. Kidney Int 51:1355-1360, 1997
18. Chua CC, Hamdy RC, Chua BH: Regulation of throm-bospondin-1 production by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta 1357:209-214, 1997
19. Kagami S, Border WA, Miller DE, Noble NA: Angio-tensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
20. Hugo C, Pichler R, Shankland S, et al: Thrombospondin 1 (TSP1), and TGF-/3 activating protein, precedes and predicts tubulointerstitial fibrosis in glomerular disease. Kidney Int 53:302-311, 1998
21. Schnermann JB, Zhu XL, Shu X, et al: Regulation of endothelin production and secretion in cultured collecting duct cells by endogenous transforming growth factor-beta. Endocrinology 137:5000-5008, 1996
22. Hocher B, Thöne-Reineke C, Rohmeiss P, et al: Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 99:6 1380-1389, 1997
23. Sanderson N, Factor V, Nagy P, et al: Hepatic expression of mature transforming growth factor beta-1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A 92:2572-2576, 1995
24. McKay NO, Power DA, MacLeod AM, Haites NE: Increased fibronectin incorporation into extracellular matrix in response to platelet-derived growth factor is mediated by transforming growth factor beta. Exp Nephrol 3:142, 1995
25. Throckmorton DC, Brogden AP, Min B, et al: PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int 48:111-117, 1995
26. Kim SJ, Angel P, Lafyatis R, et al: Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cel Biol 10:1492-1497, 1990
27. Pierce OF, Mustoe TA, Lingelbach J, et al: Trans-forming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: Possible regulation in macrophages by platelet-derived growth factor. Proc Natl Acad Sci U S A 86:2229-2233, 1989
28. Van Obberghen-Schilling E, Roche NS, Flanders KC, et al: Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J Biol Chem 263:7741-7746, 1988
29. Phillips AO, Steadman R, Topley N, et al: Elevated D-glucose concentrations modulate TGF-beta 1 synthesis by human cultured renal proximal tubular cells. The permissive role of platelet-derived growth factor. Am J Pathol 147:362374, 1995
30. Kuncio GS, Neilson EG, Haverty T: Mechanisms of tubulointerstitial fibrosis. Kidney Int 39:550-556, 1991
31. 53 and p21 (WAF1) in experimental renal fibrosis. Kidney Int 49: S83-S87, 1996 (Suppl 54)
32. Engelmeyer E, Van Goor H, Edwards DR, Diamond JR: Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase 1, -2, -3 in experimental hydronephrosis. J Am Soc Nephrol 5:1675-1683, 1995
33. Diamond JR, Levinson M, Kreisberg R, Ricardo SD: Increased expression of decorin in experimental hydronephrosis. Kidney Int 51:1133-1139, 1997
34. 21 (VVAF1) expression during unilateral ureteral obstruction. Kidney Int 50: S-84-S-92, 1996 (Suppl 57)
35. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 26:1821-1828, 1994
36. Egido J, Gomez-Chiarri M, Ortiz A, et al: Role of tumor necrosis factor-a in the pathogenesis of glomerular diseases. Kidney Int 43:S59-S64, 1993 (Suppl 39)
37. Baud L, Fouqueray B, Philippe C, Amram A: Tumor necrosis factor alpha and mesangial cells. Kidney Int 41:600603, 1992
38. Ortiz A, Bustos C, Alcazar A, et al: Involvement of tumor necrosis factor-a in the pathogenesis of experimental and human glomerulonephritis, in Grunfeld JP, Bach JF, Kreis H, Maxwell MH (eds): Advances in Nephrology. St. Louis, MO, Mosby, 1995, pp 53-77
39. Wuthrich RP, Glimcher LH, Yui MA, et al: MHC class II antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 37:783-792, 1990
40. Kaneto H, Morrissey J, McCracken R, et al: The expression of mRNA for tumor necrosis factor-α increases in the obstructed kidney of rats soon after unilateral ureteral ligation. Nephrology 2:161-166, 1996
41. Wolf G, Aberle S, Thaiss F, et al: TNF-a induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells. Kidney Int 44:795-804, 1993
42. Mulligan MS, Johnson KJ, Todd RF, et al: Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest 91:577-587, 1993
43. Schreiner GF, Harris KP, Purkerson ML, Klahr S: Immunological aspects of acute ureteral obstruction: Immune cell infiltrate in the kidney. Kidney Int 34:487-493, 1988
44. Larrick JW, Wright SC: Cytotoxic mechanism of tumor necrosis factor-a. FASEB J 4:3215-3223, 1990
45. Laster SM, Wood JG, Gooding LR: Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J Immunol 141:2629-2634, 1988
46. Itoh N, Yonehara S, Ishii A, et al: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243, 1991
47. Gobe GC, Axelsen RA: Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. Lab Invest 56:273-281, 1987
48. Kennedy WA II, Stenberg A, Lackgrew G, et al: Renal tubular apoptosis after partial ureteral obstruction. J Urol 152:658-664, 1994
49. Baeurle PA, Henkel T: Function and activation of NFKB in the immune system. Annu Rev Immunol 12:141-179, 1994
50. Barnes PJ, Karin M: Nuclear factor-kappa; A pivotal transcription factor in chronic inflammatory diseases. N Engl JMed 336:1066-1071, 1997
51. Wendt T, Zhang YM, Bierhaus A, et al: Tissue factor expression in an animal model of hydronephrosis. Nephrol Dial Transplant 10:1820-1828, 1995
52. Morrissey JJ, Klahr S: Enalapril decreases nuclear factor B activation in the kidney with ureteral obstruction. Kidney Int 52:926-933, 1997
53. Lentsch AB, Shanley TP, Sarma V, Ward PA: In vivo suppression of NF-κB and preservation of Lκ.Bα by interleukin-10 and interleukin-13. J Clin Invest 100:2443-2448, 1997
54. Border WA, Ruoslahti E: Transforming growth factor-β in disease; The dark side of tissue repair. J Clin Invest 90:1-7, 1992
55. Mizra A, Liu S-L, Frizell E, et al: A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-KB. Am J Physiol 272 (Gastrointest Liver Physiol 35): G281-G288, 1997
56. Butler W: The nature and significance of osteopontin. Connective Tissue Res 23:123-136, 1989
57. Pichler R, Giachelli CM, Lombardi D, et al: Tubulointerstitial disease in glomerulonephritis; Potential role of osteopontin (uropontin). Am J Pathol 144:915-926, 1994
58. Johnson TS, Griffin M, Thomas GL, et al: The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. J Clin Invest 99:2950-2960, 1997
59. Lee KS, Buck M, Houglum K, Chojkier M: Activation of hepatic stellate cells by TGFα and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 96:2461-2468, 1995
60. Nagle RB, Johnson ME, Jervis HR: Proliferation of renal interstitial cells following injury induced by ureteral obstruction. Lab Invest 35:18-22, 1976
61. Pedagogos E, Hewitson T, Fraser I, et al: Myofibroblasts and arteriolar sclerosis in human diabetic nephropathy. Am J Kidney Dis 29:912-918, 1997
62. Strutz F, Okada H, Lo CW, et al: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130:393-405, 1995
63. Tulchinsky E, Prokhortchouk E, Georgiev G, Lukanidin E: A KB-related binding site is an integral part of the mtsl gene composite enhancer element located in the first intron of the gene. J Biol Chem 272:4828-4835, 1997
64. Li J, Brazier AR: Angiotensinogen gene activation by angiotensin II is mediated by the Rel A (Nuclear Factor-κB p65) transcription factor: One mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol 10:252-264, 1996
65. Brasier AR, Li J: Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 27 (part 2):465-475, 1996
66. Brasier AR, Li J, Wimbish KA: Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension 27:1009-1017, 1996
67. Klahr S, Morrissey JJ: Angiotensin II and gene expression in the kidney. Am J Kidney Dis 31:171-176, 1998
68. Modi KS, Morrissey J, Shah SV, et al: Effects of probucol on renal function in rats with bilateral ureteral obstruction. Kidney Int 38:843-850, 1990
69. Ricardo SK, Ding G, Eufemio M, Diamond JR: Anti-oxidant expression in experimental hydronephrosis: Role of mechanical stretch and growth factors. Am J Physiol 272 (Renal Fluid Electrol Physiol 41):F789-F798, 1997
70. Morrissey J, Duan L, Klahr S: N-acetylcysteine treatment alters nuclear transcription factor activity and monocyte infiltration during ureteral obstruction. J Am Soc Nephrol 7:1830, 1996 (abstr)
71. Sen C-K, Packer L: Antioxidant and redox regulation of gene transcription. FASEB J 10:709-720, 1996
72. Klahr S, Morrissey J: Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney Int 52:3-111-5-114, 1997 (SuppI 63)
73. Morrissey JJ, Ishidoya S, McCracken R, Klahr S: Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 7:2202-2212, 1996
74. Reyes AA, Porras BH, Chasalow FI, Klahr S: L-arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin-induced nephrosis. Kidney Int 45:1346-1354, 1994
75. Ishidoya S, Morrissey J, McCracken R, Klahr S: Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 49:1110-1119, 1996
76. Morrissey J, Duan L, Klahr S: Angiotensin Type II receptor antagonism in ureteral obstruction. J Am Soc Nephrol 7:1761, 1996 (abstr)
77. Ma J, Hideki H, Fogo A, et al: Accelerated fibrosis nd collagen deposition develop in the renal interstitium of angiotensin type II (AT2) receptor null mutant mice during ureteral obstruction. J Am Soc Nephrol 8:622A, 1997 (abstr)
78. Yarger WE, Schocken DD, Harris RH: Obstructive nephropathy in the rat: Possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function. J Clin Invest 65:400-412, 1980
79. Purkerson ML, Klahr S: Prior inhibition of vasocon-strictors normalizes GFR in postobstructed kidneys. Kidney Int 35:1305-1314, 1989
80. Reyes AA, Robertson G, Klahr S: Role of vasopressin in rats with bilateral ureteral obstruction. Proc Soc Exp Biol Med 197:49-55, 1991
81. Reyes AA, Lefkowith J, Pippin J, Klahr S: Role of the 5-Iipooxygenase pathway in obstructive nephropathy. Kidney Int 41:100-106, 1992
82. Klahr S, Harris KPG, Purkerson ML: Effect of obstruction on renal functions. Pediatr Nephrol 2:34-42, 1988
83. Reyes AA, Klahr S: Role of platelet-activating factor in renal function in normal rats and rats with bilateral ureteral obstruction. Proc Soc Exp Biol Med 198:572-578, 1991
84. Reyes AA, Klahr S: Renal function after release of ureteral obstruction: Role of endothelin and the renal artery endothelium. Kidney Int 42:632-638, 1992
85. Johnson RJ, Alpers CE, Yoshimura A, et al: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
86. Tang WW, Ulich TR, Lacey DL, et al: Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 148:1169-1180, 1996
87. Jones CL, Buch S, Post M, et al: Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. Kidney Int 40:1020-1031, 1991
88. Lafayette R, Mayer G, Meyer T: The effect of blood pressure reduction on cyclosporine nephrotoxicity in the rat. J Am Soc Nephrol 3:1892-1899, 1993
89. Zoja C, Donadelli R, Corna D, et al: The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis 29:254-264, 1997